Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: a multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole

Ishigooka J 1 , Nakamura J 2 , Fujii Y 3 , Iwata N 4 , Kishimoto T 5 , Iyo M 6 Show all authors , Uchimura N 7 , Nishimura R 8 , Shimizu N 9 , ALPHA Study Group

Affiliations 

  • 1 Department of Psychiatry, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. Electronic address: [email protected]
  • 2 Department of Psychiatry, School of Medicine University of Occupational and Environmental Health, 1-1, Iseigaoka, Yahata-nishi-ku, Kitakyushu, Fukuoka 807-8555, Japan
  • 3 Department of Neuropsychiatry, Yamanashi Prefectural Kita Hospital, 3314-13, Kamijou-minamiwari Asahimachi, Nirasakishi, Yamanashi 407-0046, Japan
  • 4 Department of Psychiatry, Fujita Health University School of Medicine, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan
  • 5 Department of Psychiatry, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan
  • 6 Department of Psychiatry, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba 260-8670, Japan
  • 7 Department of Neuropsychiatry, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka 830-0011, Japan
  • 8 Department of Psychiatry, Faculty of Medicine, Fukuoka University, 8-19-1, Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
  • 9 Otsuka Pharmaceutical Co., Ltd., Shinagawa Grand Central Tower, 2-16-4, Konan, Minato-ku, Tokyo 108-8242, Japan
Schizophr Res, 2015 Feb;161(2-3):421-8.
PMID: 25556976 DOI: 10.1016/j.schres.2014.12.013

Abstract

This study was designed to evaluate efficacy and safety of aripiprazole once-monthly (AOM) by verifying non-inferiority of AOM to oral aripiprazole in Asian patients with schizophrenia.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications